Charles River Laboratories | 当期純利益



Net Income 変化する 日付
Agilent USD 318M 33M 2025-01
Align Technology USD 93.23M 10.58M 2025-03
Bio-Rad Laboratories USD 64M 779.8M 2025-03
Bruker USD 13.7M 27.2M 2024-12
Cardinal Health USD 506M 106M 2025-03
Charles River Laboratories USD -215699000 284.38M 2024-12
Cigna USD 1.42B 685M 2024-12
CVS Health USD 1.78B 135M 2025-03
Danaher USD 954M 132M 2025-03
Dentsply International USD -430000000 64M 2024-12
Elevance Health USD 2.18B 1.76B 2025-03
Galapagos EUR -153403000 178.71M 2025-03
Hologic USD -17400000 218.4M 2025-03
Humana USD 1.24B 1.94B 2025-03
Illumina USD 187M 518M 2024-12
Incyte USD 158.2M 43.01M 2025-03
IQVIA Holdings USD 437M 152M 2024-12
Laboratory Of America USD 212.8M 69.4M 2025-03
Lonza CHF 329M 85M 2024-06
McKesson USD 879M 638M 2024-12
Merck EUR 667M 142M 2024-12
Mettler Toledo International USD 163.59M 88.71M 2025-03
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Quest Diagnostics USD 220M 2M 2025-03
Revvity USD 42.24M 52.41M 2025-03
Thermo Fisher Scientific USD 1.51B 323M 2025-03
United Therapeutics USD 322.2M 20.9M 2025-03
UnitedHealth USD 6.29B 749M 2025-03
Walgreens Boots Alliance USD -2853000000 2.59B 2025-02
Waters USD 231.4M 69.9M 2024-12
West Pharmaceutical Services USD 89.8M 40.3M 2025-03



Charles River Laboratories 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.